Here are five observations:
1. The company currently has a consensus target price of $40.97.
2. Smith & Nephew has a one-year low of $28.87 and a one-year high of $39.80.
3. The stock’s 50-day moving average is $34.50 and its 200-day moving average is $35.04.
4. The company has a market cap of $15.94 billion.
5. In June, Smith & Nephew announced plans to acquire Zimmer’s unicondylar knee system in the United States market.
More articles on devices:
NuVasive names new executive vice president — 5 key notes
J&J Orthopedics sales drop 5.6% in Q2: 5 key notes
Surgical Science features Zyga’s SImmetry SI joint fusion system: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
